2021
DOI: 10.1007/s43032-021-00705-0
|View full text |Cite
|
Sign up to set email alerts
|

Willingness of Women with Endometriosis Planning to Undergo IVF to Participate in a Randomized Clinical Trial and the Effects of the COVID-19 Pandemic on Potential Participation

Abstract: The Pre-IVF Treatment with a GnRH Antagonist in Women with Endometriosis (PREGnant) Trial (clinicaltrials.gov no. NCT04173169) was designed to test the hypothesis that 60-day pre-treatment with an oral GnRH antagonist in women with documented endometriosis and planning an IVF cycle will result in a superior live birth rate to placebo. Eight hundred fourteen women are required from 4 national sites. To determine the feasibility of using an electronic medical record (EMR)-based strategy to recruit 204 participan… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
5

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(6 citation statements)
references
References 19 publications
0
1
0
5
Order By: Relevance
“…10,11 However, feasibility surveys for a placebo-controlled endometriosis trial in the United States indicate a surprisingly high (90%) agreement to participate. 12 These disparate findings may reflect the daily impacts of the condition being treated, and the perceived effectiveness of treatment, but may also be influenced by cultural differences between the countries.…”
Section: Discussionmentioning
confidence: 99%
“…10,11 However, feasibility surveys for a placebo-controlled endometriosis trial in the United States indicate a surprisingly high (90%) agreement to participate. 12 These disparate findings may reflect the daily impacts of the condition being treated, and the perceived effectiveness of treatment, but may also be influenced by cultural differences between the countries.…”
Section: Discussionmentioning
confidence: 99%
“…연구 수행 지역을 살펴보면 유럽에서 3편[이탈리아 (Cirillo et al, 2021), 폴란드 (Ilska et al, 2021), 세르비아 (Mitrović et al, 2021)], 중동에서 2편[이스라엘 (Aizer et al, 2022;Avraham (Cao et al, 2021), 대만 (Lin et al, 2021)]의 논문이 발간되었으며 미 국 및 캐나다 5편[미국 (Lawson et al, 2021;Pretzel et al, 2022;Seifer et al, 2021;Vaughan et al, 2020), 캐나다 (Vastis et al, 2022)]에서 최다 논문을 발표하였고, 브라질에서 발표한 논문 이 1편 (Braga et al, 2020)이었다. (Cheng et al, 2018;Freeman et al, 2018;Jung & Kim, 2017;Massarotti et al, 2019;Nicoloro-SantaBarbara et al, 2018).…”
Section: 최종 13편의 문헌에 대한 일반적 특성은unclassified
“…이 연구에서는 PRISMA-ScR의 스코핑 리뷰 방 법을 참고하여 연구 결과를 분석 후 합의된 결론을 도출하였으 며, 고찰된 결과를 요약한 표 및 그림으로 제시하였다 (Tricco et al, 2018). (Braga et al, 2020;Vaughan et al, 2020), 2021년 7편 (Cao et al, 2021;Cirillo et al, 2021;Ilska et al, 2021;Lawson et al, 2021;Lin et al, 2021;Mitrović et al, 2021;Seifer et al, 2021), 2022년 4편 (Aizer et al, 2022;Avraham et al, 2022;Pretzel et al, 2022;Vastis et al, 2022)이었고 모두 국외 저널에 발표된 연구였다.…”
unclassified
See 2 more Smart Citations